SOTERA HEALTH COMPANY Operating Cash Flow
SOTERA HEALTH COMPANY (SHC) reported Operating Cash Flow of $117.93 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- SOTERA HEALTH COMPANY net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $88.50M, a 54.13% increase year-over-year.
- SOTERA HEALTH COMPANY net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $29.43M, a 46.98% decline year-over-year.
- SOTERA HEALTH COMPANY net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $103.10M, a 85.05% increase year-over-year.
- SOTERA HEALTH COMPANY net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $71.15M, a 26.99% decline year-over-year.
- SOTERA HEALTH COMPANY net cash provided by (used in) operating activities for fiscal 2025 was $287.19M, a 28.12% increase from fiscal 2024.
- SOTERA HEALTH COMPANY net cash provided by (used in) operating activities for fiscal 2024 was $224.16M.
- SOTERA HEALTH COMPANY net cash provided by (used in) operating activities for fiscal 2023 was -$147.73M, a 153.15% decline from fiscal 2022.
- SOTERA HEALTH COMPANY net cash provided by (used in) operating activities for fiscal 2022 was $277.96M, a 1.27% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $88.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $117.93M 10-Q · filed 2026-08-06 | $221.03M derived: sum of 3 quarters · filed 2026-08-06 | $292.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $29.43M 10-Q · filed 2026-05-05 | $132.54M derived: sum of 2 quarters · filed 2026-05-05 | $203.69M derived: sum of 3 quarters · filed 2026-05-05 | $261.11M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $103.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $174.26M derived: sum of 2 quarters · filed 2026-02-24 | $231.67M derived: sum of 3 quarters · filed 2026-08-06 | $287.19M 10-K · filed 2026-02-24 |
| 2025-09-30 | $71.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $128.57M derived: sum of 2 quarters · filed 2026-08-06 | $184.09M 10-Q · filed 2025-11-04 | $239.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $57.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $112.94M 10-Q · filed 2026-08-06 | $168.65M derived: sum of 3 quarters · filed 2026-08-06 | $266.11M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $55.52M 10-Q · filed 2026-05-05 | $111.24M derived: sum of 2 quarters · filed 2026-05-05 | $208.69M derived: sum of 3 quarters · filed 2026-05-05 | $269.99M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $55.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $153.17M derived: sum of 2 quarters · filed 2026-02-24 | $214.47M derived: sum of 3 quarters · filed 2026-02-24 | $224.16M 10-K · filed 2026-02-24 |
| 2024-09-30 | $97.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $158.75M derived: sum of 2 quarters · filed 2025-11-04 | $168.45M 10-Q · filed 2025-11-04 | $281.57M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $61.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $70.99M 10-Q · filed 2025-08-08 | $184.12M derived: sum of 3 quarters · filed 2026-02-24 | $225.97M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $9.70M 10-Q · filed 2025-05-01 | $122.82M derived: sum of 2 quarters · filed 2026-02-24 | $164.67M derived: sum of 3 quarters · filed 2026-02-24 | -$171.90M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $113.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $154.97M derived: sum of 2 quarters · filed 2026-02-24 | -$181.60M derived: sum of 3 quarters · filed 2026-02-24 | -$147.73M 10-K · filed 2026-02-24 |
| 2023-09-30 | $41.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$294.73M derived: sum of 2 quarters · filed 2024-11-05 | -$260.86M 10-Q · filed 2024-11-05 | -$158.93M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$336.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$302.70M 10-Q · filed 2024-08-05 | -$200.78M derived: sum of 3 quarters · filed 2025-02-27 | -$133.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $33.87M 10-Q · filed 2024-05-02 | $135.80M derived: sum of 2 quarters · filed 2025-02-27 | $203.58M derived: sum of 3 quarters · filed 2025-02-27 | $261.87M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $101.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $169.71M derived: sum of 2 quarters · filed 2025-02-27 | $227.99M derived: sum of 3 quarters · filed 2025-02-27 | $277.96M 10-K · filed 2025-02-27 |
| 2022-09-30 | $67.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $126.07M derived: sum of 2 quarters · filed 2023-11-01 | $176.03M 10-Q · filed 2023-11-01 | $242.39M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $58.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $108.26M 10-Q · filed 2023-08-03 | $174.61M derived: sum of 3 quarters · filed 2024-02-27 | $255.54M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $49.97M 10-Q · filed 2023-05-03 | $116.32M derived: sum of 2 quarters · filed 2024-02-27 | $197.26M derived: sum of 3 quarters · filed 2024-02-27 | $275.35M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $66.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $147.29M derived: sum of 2 quarters · filed 2024-02-27 | $225.39M derived: sum of 3 quarters · filed 2024-02-27 | $281.55M 10-K · filed 2024-02-27 |
| 2021-09-30 | $80.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $159.03M derived: sum of 2 quarters · filed 2022-11-02 | $215.19M 10-Q · filed 2022-11-02 | $237.04M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $78.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $134.26M 10-Q · filed 2022-08-04 | $156.10M derived: sum of 3 quarters · filed 2023-02-28 | $202.15M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $56.16M 10-Q · filed 2022-05-05 | $78.00M derived: sum of 2 quarters · filed 2023-02-28 | $124.06M derived: sum of 3 quarters · filed 2023-02-28 | $171.05M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $21.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $67.90M derived: sum of 2 quarters · filed 2023-02-28 | $114.89M derived: sum of 3 quarters · filed 2023-02-28 | $120.58M 10-K · filed 2023-02-28 |
| 2020-09-30 | $46.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $93.05M derived: sum of 2 quarters · filed 2021-11-10 | $98.74M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $47.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $52.69M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $5.69M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $149.04M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |